Alkermes, Inc. Sustainability Profile
Alkermes, Inc., a prominent biopharmaceutical company headquartered in the United States, focuses on developing innovative therapies for central nervous system (CNS) disorders and addiction. Founded in 1987, Alkermes has established itself as a leader in the industry, with significant operational presence across North America and Europe. The company is renowned for its unique drug delivery technologies and a robust portfolio of products, including treatments for schizophrenia, depression, and opioid dependence. Alkermes' commitment to addressing complex medical needs has positioned it favourably in the market, with notable achievements in advancing patient care through its proprietary formulations. With a strong emphasis on research and development, Alkermes continues to drive innovation in the biopharmaceutical landscape.
DitchCarbon Score
How does Alkermes, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Alkermes, Inc.'s score of 25 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Alkermes, Inc.'s reported carbon emissions
Alkermes, Inc., headquartered in the US, has reported its carbon emissions data for the years 2015 to 2017. In 2017, the company recorded Scope 1 and 2 emissions of approximately 125,000 kg CO2e per employee, reflecting a decrease from about 140,000 kg CO2e per employee in 2016 and about 179,000 kg CO2e per employee in 2015. This trend indicates a commitment to reducing emissions intensity relative to its workforce. Despite these figures, Alkermes has not disclosed specific Scope 1, 2, or 3 emissions totals, nor has it set formal reduction targets through initiatives such as the Science Based Targets initiative (SBTi). The company is a current subsidiary of Alkermes plc, and its emissions data may be influenced by the broader corporate family context. Alkermes has not outlined any specific climate pledges or reduction initiatives in the available data. However, the company’s focus on emissions per employee suggests an ongoing effort to improve its environmental performance. As the industry increasingly prioritises sustainability, Alkermes may need to establish clearer climate commitments to align with global standards and stakeholder expectations.
How Carbon Intensive is Alkermes, Inc.'s Industry?
How Carbon Intensive is Alkermes, Inc.'s Location?
Alkermes, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Alkermes, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
